EVALUATION OF THE USE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61164/rmnm.v12i3.3138Keywords:
Cardioversor Desfibrilador Implantável; Cardiopatia Congênita; Crianças; Adolescentes; Revisão Sistemática.Abstract
Sudden Cardiac Death can be one of the first manifestations of congenital heart diseases in children and adolescents; thus, early diagnosis and appropriate intervention are of utmost importance. In this context, this systematic review aims to evaluate the outcomes of using implantable cardioverter-defibrillators (ICDs) in children and adolescents with congenital heart diseases from January 2018 to June 2023, clarifying their complications and elucidating the results obtained in recent studies to contribute to medical knowledge. This research was conducted through the databases PubMed, Lilacs, and Scielo, selecting articles that assessed the use of ICDs in children and adolescents with congenital heart diseases. Out of an initial 379 studies, 14 were included in the final analysis. A total of 650 patients were analyzed, with 376 males and 274 females. The cardiac diseases were categorized into three groups: Primary Electrical Disease, Congenital Heart Disease, and Cardiomyopathies. Complications occurred in 134 patients (20.58%), appropriate shocks in 155 (23.81%), and inappropriate shocks in 120 patients (18.54%). The average age of the patients assessed was 14.03 years, the average follow-up time was 66.4 months, and the mortality rate in this population was 2.15%.
References
REFERÊNCIAS
Ailes EC, Gilboa SM, Riehle-Colarusso T, Johnson CY, Hobbs CA, Correa A, et al. Prenatal diagnosis of nonsyndromic congenital heart defects. Prenat Diagn. 2014 Mar;34(3):214–22.
Rella V, Parati G, Crotti L. Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators. Vol. 8, Frontiers in Pediatrics. Frontiers Media S.A.; 2020.
Miller JD, Yousuf O, Berger RD. The implantable cardioverter-defibrillator: An update. Vol. 25, Trends in Cardiovascular Medicine. Elsevier Inc.; 2015. p. 606–11.
Mori H, Sumitomo N, Tsutsui K, Fukunaga H, Hayashi H, Nakajima H, et al. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry. Int J Cardiol. 2023 Jan 15;371:204–10.
Koury A, Jurubeba X, Saleh A, Amanda K;, Fraga S, Phillipe J, et al. CAPÍTULO 6 ETIOLOGIA, POSSÍVEIS FATORES DE RISCOS E ASPECTOS RELACIONADOS À IDENTIFICAÇÃO E PREVENÇÃO DA MORTE SÚBITA CARDÍACA.
Pitak MJ, Jastrzębski M, Rudek-Budzyńska A, Weryński P, Winter J, Góreczny S. Subcutaneous implantable cardioverter-defibrillator and the two-incision intermuscular technique in pediatric patients - A single center experience. Kardiol Pol. 2021 Sep 30;79(9):1025–7.
Teixeira RA, Fagundes AA, Junior JMB, de Oliveira JC, de Tarso Jorge Medeiros P, Valdigem BP, et al. Brazilian Guidelines for Cardiac Implantable Electronic Devices – 2023. Arq Bras Cardiol. 2023;120(1).
Song MK, Uhm JS, Baek JS, Yoon JK, Na JY, Yu HT, et al. Clinical outcomes of implantable cardioverter-defibrillator in pediatric patients - A Korean multicenter study. Circulation Journal. 2021;85(8):1356–64.
Olde Nordkamp LRA, Postema PG, Knops RE, van Dijk N, Limpens J, Wilde AAM, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016 Feb;13(2):443–54. (https://pubmed.ncbi.nlm.nih.gov/26385533/)
Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJM, et al. Implantable cardioverter-defibrillators in adults with congenital heart disease: A systematic review and meta-analysis. Eur Heart J. 2016 May 7;37(18):1439–48. (https://pubmed.ncbi.nlm.nih.gov/26873095/)
Medeiros P, Santos M, Arantes C, Pereira VH, Rocha S. Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review. Heart & Lung. 2023 Jul;60:1–7. (https://pubmed.ncbi.nlm.nih.gov/36863123/)
Roston TM, Jones K, Hawkins NM, Bos JM, Schwartz PJ, Perry F, et al. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review. Heart Rhythm. 2018 Dec;15(12):1791–9. (https://pubmed.ncbi.nlm.nih.gov/30063211/)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
